To the Editor There is now convincing evidence that ketamine has properties to provide prompt antidepressant effects, especially in patients with resistant mood and anxiety disorders.1 Eventually, ketamine will be included in our daily practice. However, in addition to the concerns addressed by Sanacora et al,1 there are a few further complications to be taken into consideration by any practitioner.
Golzari SEJ, Mahmoodpoor A. Ketamine for the Treatment of Depression. JAMA Psychiatry. 2017;74(9):971. doi:10.1001/jamapsychiatry.2017.1779
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: